CERS - AABB position should solidify growth for the long term

CERS has pcodes (with a premium) backing by majority of blood banks, the AABB. ARC will be on board. Pathogen inactivated RBCs would not yield the same storage lifespan but would obsolete current mandatory tests. Cers should have solid growth until RBCs are approved.